Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Penter L, Zhang Y, Savell A, Huang T, et al. Blood 2021;137:3212-3217.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Penter L, Zhang Y, Savell A, Huang T, et al. Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Blood 2021;137:3212-3217.
PMID: 33720354